Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Int J Environ Res Public Health ; 20(1)2022 12 29.
Article in English | MEDLINE | ID: covidwho-2245581

ABSTRACT

National Test for Poles' Health is an online study conducted on a large group of Polish Internet users. For the purpose of this study, 64,732 subjects (48.8% female) over 65 years old were included. Subjects provided answers on the level of physical activity (PA) they engage in, prevalence of non-communicable diseases (obesity, hypertension, diabetes, heart diseases, chronic obstructive pulmonary disease (COPD), depression, cancer) and subjective physical and psychological health. Additionally, their Body Mass Index (BMI) and prevalence of multimorbidity was assessed. We found that older people who engage in at least 2 h of physical activity/week had significantly lower prevalence of hypertension, obesity and heart diseases than those who engaged in 1-1.5 h/week or less than 1 h/week. Multimorbidity was present in 33.2% of subjects from the most active group and 52.6% of the least active ones. Subjective physical and psychological health was rated as "very good" by 26.6% and 41.2%, respectively, by subjects from the most active group. Only 9.1% of the least active subjects rated their physical health as "very good" and only 27.4% rated their psychological health as such. Regular physical activity may be a helpful tool in combating the reduced well-being of older people affected by the isolation caused by the COVID-19 pandemic. Unfortunately, over 65% of respondents claimed to engage in less than 1 h of PA a week or less.


Subject(s)
COVID-19 , Heart Diseases , Hypertension , Humans , Female , Aged , Male , Multimorbidity , Poland/epidemiology , Pandemics , COVID-19/epidemiology , Health Behavior , Exercise/psychology , Obesity
2.
Cardiol J ; 30(3): 344-352, 2023.
Article in English | MEDLINE | ID: covidwho-2202811

ABSTRACT

BACKGROUND: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, numerous cardiology departments were reorganized to provide care for COVID-19 patients. We aimed to compare the impact of the COVID-19 pandemic on hospital admissions and in-hospital mortality in reorganized vs. unaltered cardiology departments. METHODS: The present research is a subanalysis of a multicenter retrospective COV-HF-SIRIO 6 study that includes all patients (n = 101,433) hospitalized in 24 cardiology departments in Poland between January 1, 2019 and December 31, 2020, with a focus on patients with acute heart failure (AHF). RESULTS: Reduction of all-cause hospitalizations was 50.6% vs. 21.3% for reorganized vs. unaltered cardiology departments in 2020 vs. 2019, respectively (p < 0.0001). Considering AHF alone respective reductions by 46.5% and 15.2% were registered (p < 0.0001). A higher percentage of patients was brought in by ambulance to reorganized vs. unaltered cardiology departments (51.7% vs. 34.6%; p < 0.0001) alongside with a lower rate of self-referrals (45.7% vs. 58.4%; p < 0.0001). The rate of all-cause in-hospital mortality in AHF patients was higher in reorganized than unaltered cardiology departments (10.9% vs. 6.4%; p < 0.0001). After the exclusion of patients with concomitant COVID-19, the mortality rates did not differ significantly (6.9% vs. 6.4%; p = 0.55). CONCLUSIONS: A greater reduction in hospital admissions in 2020 vs. 2019, higher rates of patients brought by ambulance together with lower rates of self-referrals and higher all-cause in-hospital mortality for AHF due to COVID-19 related deaths were observed in cardiology departments reorganized to provide care for COVID-19 patients vs. unaltered ones.


Subject(s)
COVID-19 , Cardiology , Heart Failure , Humans , COVID-19/epidemiology , Pandemics , Retrospective Studies , Heart Failure/diagnosis , Heart Failure/epidemiology , Heart Failure/therapy , Hospital Mortality
3.
Int J Occup Med Environ Health ; 2022 Sep 28.
Article in English | MEDLINE | ID: covidwho-2056446

ABSTRACT

OBJECTIVES: Dyspnea is one of the most predominant symptom in clinical practice. There is a lack of data about incidents of dyspnea among Polish adults therefore it would be important to establish prevalence of this symptom before COVID-19 pandemic to assess the impact of this infection on the functioning of the adult Polish population in the future. The aim of the study was to establish prevalence of dyspnea in adult Polish population. MATERIAL AND METHODS: It was an observational-cross-sectional study, with representative sample of adult Poles aged 18-79 years. The 2413 participants were surveyed. Responders were asked if and when dyspnea occurs and what is its severity in relation to one of four categories (A, B, C, and D) describing the impact of dyspnea on reduced exercise tolerance and daily activities. RESULTS: The 67.1% of the respondents answered negatively to all question about experiencing dyspnea (females (F) 61% vs. males (M) 74%, p < 0.05). Dyspnea only during intense physical exertion (A), was reported by 22.8% (F 26.2% vs. M 19.2%, p = 0.07). Dyspnea limiting daily activities (B, C and D) was reported by 10.1% (F 13.1% vs. M 7%, p < 0.05). Significant differences in the severity of dyspnea were found between the age groups. People diagnosed with chronic heart failure or lung diseases significantly more often reported dyspnea than people without these conditions. CONCLUSIONS: Every tenth Pole reported dyspnea limiting performing activities of daily living. Additionally, about 20% of Poles experienced dyspnea considered as "gray area," only during intense physical exertion, that requires deepening and clarifying the medical history.

4.
Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarzadzanie ; 18(3):193-201, 2020.
Article in Polish | ProQuest Central | ID: covidwho-1810954

ABSTRACT

Public health community worldwide encouraged by successes of former campaigns have always accepted vaccination as the most effective way to handle infectious diseases pandemics. Even before the outburst of SARS-CoV-2 pandemic in many countries mandatory vaccination against many diseases, especially child related had been implemented. From among 193 countries under study in as many as 105 (54%) such obligation existed and in 62 of them (59%) at least one form of punishment or harm for those opposing was involved. Following this sort of available solutions and facing COVID-19 pandemic disaster the authors on behalf of the Public Health Committee of the Polish Academy of Science recommend to the government implementation od mandatory vaccination against COVID-19 for all workers in sectors of health care, education and welfare.

5.
Kardiol Pol ; 80(1): 5-15, 2022.
Article in English | MEDLINE | ID: covidwho-1687878

ABSTRACT

The pandemic of COVID-19, which in Poland raised all-cause and cardiovascular disease (CVD) death rates by over 15% only in 2020, naturally decreased the attention to the prevention of CVD. Nevertheless, the reports on the characteristics of COVID-19 patients and especially on factors related to the severe or fatal outcome of the disease included information on more frequent CVD risk factors and atherosclerotic CVD. This article reviews the evidence on the exposure to CVD risk factors in the Polish adult population and discusses evidence on the associations between CVD risk factors and COVID-19. CVD and CVD risk factors, obesity and diabetes, in particular, are related to the severe course or fatal outcome of COVID-19. High prevalence of CVD risk factors with an increasing prevalence of obesity and diabetes could make the Polish population more sensitive to COVID-19 incidence and put infected persons at higher risk of serious complications and fatal outcome. Likely, the increased number of CVD deaths observed during the pandemic could be explained partially by the high prevalence of CVD risk factors and atherosclerotic CVD, as well as by the direct cardiac complications of COVID-19, short-term higher risk of myocardial infarction (MI) and stroke, and possibly by the underuse of lifesaving procedures in acute and chronic CVD.


Subject(s)
COVID-19 , Cardiovascular Diseases , Myocardial Infarction , Adult , Cardiovascular Diseases/epidemiology , Humans , Myocardial Infarction/epidemiology , Pandemics , SARS-CoV-2
6.
ESC Heart Fail ; 9(1): 721-728, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1520187

ABSTRACT

AIMS: The coronavirus disease-2019 (COVID-19) pandemic has changed the landscape of medical care delivery worldwide. We aimed to assess the influence of COVID-19 pandemic on hospital admissions and in-hospital mortality rate in patients with acute heart failure (AHF) in a retrospective, multicentre study. METHODS AND RESULTS: From 1 January 2019 to 31 December 2020, a total of 101 433 patients were hospitalized in 24 Cardiology Departments in Poland. The number of patients admitted due to AHF decreased by 23.4% from 9853 in 2019 to 7546 in 2020 (P < 0.001). We noted a significant reduction of self-referrals in the times of COVID-19 pandemic accounting 27.8% (P < 0.001), with increased number of AHF patients brought by an ambulance by 15.9% (P < 0.001). The length of hospital stay was overall similar (7.7 ± 2.8 vs. 8.2 ± 3.7 days; P = not significant). The in-hospital all-cause mortality in AHF patients was 444 (5.2%) in 2019 vs. 406 (6.5%) in 2020 (P < 0.001). A total number of AHF patients with concomitant COVID-19 was 239 (3.2% of AHF patients hospitalized in 2020). The rate of in-hospital deaths in AHF patients with COVID-19 was extremely high accounting 31.4%, reaching up to 44.1% in the peak of the pandemic in November 2020. CONCLUSIONS: Our study indicates that the COVID-19 pandemic led to (i) reduced hospital admissions for AHF; (ii) decreased number of self-referred AHF patients and increased number of AHF patients brought by an ambulance; and (iii) increased in-hospital mortality for AHF with very high mortality rate for concomitant AHF and COVID-19.


Subject(s)
COVID-19 , Heart Failure , Acute Disease , Carbidopa , Drug Combinations , Heart Failure/epidemiology , Humans , Levodopa/analogs & derivatives , Pandemics , Retrospective Studies , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL